PMC:7784786 / 38-308
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 13-21 | Species | denotes | patients | Tax:9606 |
5 | 4-12 | Disease | denotes | COVID-19 | MESH:C000657245 |
24 | 251-254 | Gene | denotes | CD6 | Gene:923 |
29 | 245-250 | Species | denotes | human | Tax:9606 |
33 | 193-203 | Chemical | denotes | Itolizumab | MESH:C000597346 |
36 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 27-52 | Phenotype | denotes | cytokine-release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
T2 | 116-141 | Phenotype | denotes | cytokine-release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 77-85 | Sentence | denotes | Abstract |
T3 | 86-192 | Sentence | denotes | In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. |